© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 8, 622-628,
April 19, 2000
© 2000 Oxford University Press
Pathogenesis of Paget's Disease: Epidermal Heregulin-
, Motility Factor, and the HER Receptor Family
Affiliations of authors: V. R. J. Schelfhout, E. D. Coene, S. Thys, C. R. De Potter, N. Goormaghtigh Institute for Pathology, University Hospital, Gent, Belgium; B. Delaey, N.V. Innogenetics, Zwijnaarde, Belgium; D. L. Page, Department of Pathology, Vanderbilt University Medical Center, Nashville, TN.
Correspondence to: Christian R. De Potter, M.D., N. Goormaghtigh Institute for Pathology, University Hospital, De Pintelaan 185, B-9000 Gent, Belgium (e-mail: Christian.DePotter{at}rug.ac.be).
Background and Methods: In Paget's disease of the breast, the epidermis of the nipple is infiltrated by large neoplastic cells of glandular origin. It has been hypothesized that the spread of Paget cells through the nipple epidermis is induced by a motility factor that acts via the HER2/NEU receptor. To test this hypothesis, we characterized and purified a motility factor released by keratinocytes and identified its target receptors in specimens from patients with Paget's disease and in SK-BR-3 breast adenocarcinoma cells, which overexpress HER2/NEU. Results: We isolated the motility factor from keratinocyte-conditioned medium and sequenced tryptic peptides. These sequences were used to identify the motility factor as heregulin-
, which is released by skin keratinocytes. Heregulin- induces spreading, motility, and chemotaxis of SK-BR-3 cells, as does motility factor. Motility factor activities of heregulin- are inhibited by monoclonal antibody AB2, directed against the extracellular domain of HER2/NEU, which blocks the binding of heregulin-. We used in situ hybridization to show that normal epidermal cells produce heregulin- messenger RNA and that heregulin receptors, HER3 and/or HER4, as well as their coreceptor HER2/NEU, are expressed by Paget cells. Conclusions: Heregulin- is a motility factor that is produced and released by normal epidermal keratinocytes and thus plays a key role in the pathogenesis of Paget's disease. Paget cells express heregulin receptors HER2/NEU, as well as HER3 and/or HER4, both of which function as a co-receptor of HER2/NEU. Binding of heregulin- to the receptor complex on Paget cells results in the chemotaxis of these breast cancer cells, which eventually migrate into the overlying nipple epidermis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B Brandt, D Kemming, J Packeisen, R Simon, M Helms, U Feldmann, A Matuschek, C Kersting, B Hinrichs, J-M Bidart, et al. Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility Endocr. Relat. Cancer, December 1, 2005; 12(4): 823 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shibata, A. Kokubu, S. Sekine, Y. Kanai, and S. Hirohashi Cytoplasmic p120ctn Regulates the Invasive Phenotypes of E-Cadherin-Deficient Breast Cancer Am. J. Pathol., June 1, 2004; 164(6): 2269 - 2278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Suo, B. Risberg, M. G. Karlsson, K. Villman, E. Skovlund, and J. M. Nesland The Expression of EGFR Family Ligands in Breast Carcinomas International Journal of Surgical Pathology, April 1, 2002; 10(2): 91 - 99. [Abstract] [PDF]
|
|